BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Dow
Cantor Fitzgerald
Johnson and Johnson
Argus Health
Express Scripts
Harvard Business School
Moodys
US Army
QuintilesIMS

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: RE38385

« Back to Dashboard

Summary for Patent: RE38385
Title: Storage of materials
Abstract:A material or mixture of materials which is not itself storage stable is rendered storage stable by incorporation into a water-soluble or swellable glassy or rubbery composition which can then be stored at ambient temperature. Recovery is by adding aqueous solution to the composition.
Inventor(s): Franks; Felix (Cambridge, GB), Hatley; Ross H. M. (Cambridge, GB)
Assignee: Nektar Therapeutics (San Carlos, CA)
Application Number:09/939,688
Patent Claim Types:
see list of patent claims
Composition; Formulation; Use; Dosage form; Process;

Drugs Protected by US Patent RE38385

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: RE38385

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8903593Feb 16, 1989

International Patents Family Members for US Patent RE38385

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 4924490 ➤ Subscribe
Australia 622978 ➤ Subscribe
Canada 2010058 ➤ Subscribe
Germany 69008891 ➤ Subscribe
Denmark 0383569 ➤ Subscribe
European Patent Office 0383569 ➤ Subscribe
United Kingdom 8903593 ➤ Subscribe
Japan 3068836 ➤ Subscribe
Japan H02265984 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Citi
McKinsey
Fish and Richardson
Cantor Fitzgerald
QuintilesIMS
Cerilliant
Mallinckrodt
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot